![Kelly Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelly Brady
Chief Operating Officer at
SERES THERAPEUTICS, INC.
Net worth: 41 920 $ as of 31/07/2026
Profile
Kelly M.
Brady is currently Chief Operating Officer & Executive Vice President at Seres Therapeutics, Inc. since 2026.
Former roles include Senior Director at Akebia Therapeutics, Inc. and Member-Operations Team at Osiris Therapeutics, Inc. Education includes graduate studies at The Johns Hopkins University and undergraduate studies at Lafayette College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/08/2026 | 8,679 ( 0.09% ) | 41 920 $ | 31/07/2026 |
Kelly Brady active positions
| Companies | Position | Start |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Operating Officer | 02/03/2026 |
Former positions of Kelly Brady
| Companies | Position | End |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Kelly Brady
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
38
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
- Stock Market
- Insiders
- Kelly Brady
